BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35382692)

  • 1. The role of microRNA-4723-5p regulated by c-myc in triple-negative breast cancer.
    Jin XX; Gao C; Wei WX; Jiao C; Li L; Ma BL; Dong C
    Bioengineered; 2022 Apr; 13(4):9097-9105. PubMed ID: 35382692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial to mesenchymal transition and microRNA expression are associated with spindle and apocrine cell morphology in triple-negative breast cancer.
    Koleckova M; Ehrmann J; Bouchal J; Janikova M; Brisudova A; Srovnal J; Staffova K; Svoboda M; Slaby O; Radova L; Vomackova K; Melichar B; Veverkova L; Kolar Z
    Sci Rep; 2021 Mar; 11(1):5145. PubMed ID: 33664322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bioinformatics analysis of the microRNA expression profile in the peripheral blood lymphocytes of Kazakh patients with essential hypertension in Xinjiang].
    Wang Y; Zhang L; Yang R; Shan LY; Wang L; Zhang YY; Li XZ; Ma KT
    Sheng Li Xue Bao; 2022 Oct; 74(5):751-762. PubMed ID: 36319098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of exosomal microRNAs in fresh and senescent apheresis platelet concentrates.
    Mi Z; Gong L; Kong Y; Zhao P; Yin Y; Xu H; Tian L; Liu Z
    Platelets; 2022 Nov; 33(8):1260-1269. PubMed ID: 35968647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer.
    Ouyang M; Li Y; Ye S; Ma J; Lu L; Lv W; Chang G; Li X; Li Q; Wang S; Wang W
    PLoS One; 2014; 9(5):e96228. PubMed ID: 24788655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNA-seq analysis of human vertebrae provides insight into the mechanism underlying GIOP.
    Ren H; Yu X; Shen G; Zhang Z; Shang Q; Zhao W; Huang J; Yu P; Zhan M; Lu Y; Liang Z; Tang J; Liang D; Yao Z; Yang Z; Jiang X
    Bone; 2019 Mar; 120():371-386. PubMed ID: 30503955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
    Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
    Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of key microRNAs associated with diffuse large B-cell lymphoma by analyzing serum microRNA expressions.
    Meng Y; Quan L; Liu A
    Gene; 2018 Feb; 642():205-211. PubMed ID: 29128636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA profiling identifies Forkhead box transcription factor M1 (FOXM1) regulated miR-186 and miR-200b alterations in triple negative breast cancer.
    Hamurcu Z; Sener EF; Taheri S; Nalbantoglu U; Kokcu ND; Tahtasakal R; Cınar V; Guler A; Ozkul Y; Dönmez-Altuntas H; Ozpolat B
    Cell Signal; 2021 Jul; 83():109979. PubMed ID: 33744419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiRNAs Mediate GDNF-Induced Proliferation and Migration of Glioma Cells.
    Zhang BL; Dong FL; Guo TW; Gu XH; Huang LY; Gao DS
    Cell Physiol Biochem; 2017; 44(5):1923-1938. PubMed ID: 29224008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
    Chen LL; Zhang ZJ; Yi ZB; Li JJ
    Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Hub Genes and Upstream Regulatory Factors Based on Cell Adhesion in Triple-negative Breast Cancer by Integrated Bioinformatical Analysis.
    Han YH; Wang Y; Lee SJ; Mao YY; Jiang P; Sun HN; Jin MH; Kwon T
    Anticancer Res; 2023 Jul; 43(7):2951-2964. PubMed ID: 37351977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
    Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W
    BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systems biology approach and in vitro experiment indicated Rapamycin targets key cancer and cell cycle-related genes and miRNAs in triple-negative breast cancer cells.
    Tafti A; Shojaei S; Zali H; Karima S; Mohammadi-Yeganeh S; Mondanizadeh M
    Mol Carcinog; 2023 Dec; 62(12):1960-1973. PubMed ID: 37787375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt pathway targeting reduces triple-negative breast cancer aggressiveness through miRNA regulation in vitro and in vivo.
    Mohammadi-Yeganeh S; Hosseini V; Paryan M
    J Cell Physiol; 2019 Aug; 234(10):18317-18328. PubMed ID: 30945294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.
    Ouyang X; Jiang X; Gu D; Zhang Y; Kong SK; Jiang C; Xie W
    Int J Med Sci; 2016; 13(3):195-205. PubMed ID: 26941580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of hsa-microRNA-204-5p and identification of its potential regulatory network in non-small cell lung cancer: RT-qPCR, bioinformatic- and meta-analyses.
    Liang CY; Li ZY; Gan TQ; Fang YY; Gan BL; Chen WJ; Dang YW; Shi K; Feng ZB; Chen G
    Respir Res; 2020 Feb; 21(1):60. PubMed ID: 32102656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNA profiling of human nasopharyngeal carcinoma cell lines HONE1 and CNE2 after X-ray therapy.
    Luo H; Zhong F; Jing X; Lin H; Li Y
    Adv Clin Exp Med; 2022 Jun; 31(6):671-687. PubMed ID: 35275451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [miR-93-5p promotes invasion and migration of triple negative breast cancer cells by targeting FGD5].
    Zhou D; Bai J; Hu Y; Zhang L; Zheng Q; Zhong W; Mu Q; Li H; Lyu S; Yin C
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Sep; 36(9):794-801. PubMed ID: 32967763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of dysregulated miRNAs in triple negative breast cancer: A meta-analysis approach.
    Naorem LD; Muthaiyan M; Venkatesan A
    J Cell Physiol; 2019 Jul; 234(7):11768-11779. PubMed ID: 30488443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.